Lloyds (NYSE: LYG), Imax Corporation (NASDAQ: IMAX), NutriSystem Inc (NASDAQ: NTRI), Emulex Co. (NYSE: ELX), Qlik Technologies Inc (NASDAQ: QLIK) and Protective Life Corp. (NYSE: PL) were upgraded by analysts.
Morgan Keegan upgraded Emulex Co. (ELX) from a “market perform” rating to an “outperform” rating. They have a price target of $11.00 on the company, down from $13.50.
Canaccord Genuity upgraded Imax Corporation (IMAX) was upgraded to a “buy” rating.
Goldman Sachs (NYSE:GS) upgraded Lloyds (NYSE: LYG) from a “neutral” rating to a “buy” rating.
Wedbush upgraded NutriSystem Inc (NASDAQ: NTRI) from a “neutral” rating to an “outperform” rating. They have a price target of $19.00 on the company, up from $17.00.
Bank of America (NYSE:BAC) upgraded Protective Life (PL) to a “buy” rating. They have a price target of $30.00 on the company.
BMO Capital Markets upgraded Qlik Technologies Inc (QLIK) from a “market perform” rating to an “outperform” rating. They have a price target of $40.00 on the company, up from $29.00.
Showing posts with label NutriSystem. Show all posts
Showing posts with label NutriSystem. Show all posts
Friday, July 15, 2011
Friday, April 29, 2011
NutriSystem (NTRI) (NSC) (NEWP) (NOC) (NVLS) Price Targets Adjusted
Price targets on NutriSystem Inc (NASDAQ: NTRI), Norfolk Southern Corp. (NYSE: NSC), Newport Co. (NASDAQ: NEWP), Northrop Grumman (NYSE: NOC) and Novellus Systems, Inc. (NASDAQ: NVLS) adjusted by analysts.
Jefferies (NYSE:JEF) raised their price target on Norfolk Southern Corp. (NSC) from $77.00 to $78.00.
Longbow Research raised their price target on Newport Co. (NEWP) from $22.00 to $25.00. They have a “buy” rating on the company.
JPMorgan Chase & Co. (NYSE:JPM) cut their price target on Northrop Grumman (NOC) from $53.00 to $52.00.
Wedbush raised their price target on NutriSystem Inc (NTRI) from $13.00 to $17.00. They have a “neutral” rating on the company.
RBC Capital cut their price target on Novellus Systems, Inc. (NVLS) from $38.00 to $36.00. They have an “outperform” rating on the company.
Jefferies (NYSE:JEF) raised their price target on Norfolk Southern Corp. (NSC) from $77.00 to $78.00.
Longbow Research raised their price target on Newport Co. (NEWP) from $22.00 to $25.00. They have a “buy” rating on the company.
JPMorgan Chase & Co. (NYSE:JPM) cut their price target on Northrop Grumman (NOC) from $53.00 to $52.00.
Wedbush raised their price target on NutriSystem Inc (NTRI) from $13.00 to $17.00. They have a “neutral” rating on the company.
RBC Capital cut their price target on Novellus Systems, Inc. (NVLS) from $38.00 to $36.00. They have an “outperform” rating on the company.
Friday, March 25, 2011
Should Nutrisystem (NTRI) Drop Dividend?
Shares of Nutrisystem (NASDAQ:NTRI) has struggle over the last year, and after the latest disappointing earnings report, it dropped off the table, plummeting to under $14 a share.
The current economic climate has forced weight loss companies like Nutrisystem to heavily discount to generate sales, and of course that has hammered margins and earnings.
With the current earnings estimate 46 cents a share for 2011 and 90 cents a share for 2012, that drops the company's earnings below the dividend payout, which at this time is 70 cents a share, or a yield of 5.1 percent.
There is a strong probability, and responsibility for the company to cut its dividend, even though the stock will take a big hit at that time.
Assuming that's the action Nutrisystem ultimately takes, it would be at that time investors would take a strong look at the company for a good entry point.
Nutrisystem closed Thursday at $13.73, dropping $0.09, or 0.62 percent.
The current economic climate has forced weight loss companies like Nutrisystem to heavily discount to generate sales, and of course that has hammered margins and earnings.
With the current earnings estimate 46 cents a share for 2011 and 90 cents a share for 2012, that drops the company's earnings below the dividend payout, which at this time is 70 cents a share, or a yield of 5.1 percent.
There is a strong probability, and responsibility for the company to cut its dividend, even though the stock will take a big hit at that time.
Assuming that's the action Nutrisystem ultimately takes, it would be at that time investors would take a strong look at the company for a good entry point.
Nutrisystem closed Thursday at $13.73, dropping $0.09, or 0.62 percent.
Friday, February 25, 2011
NutriSystem (NTRI), Novatel Wireless, (NVTL) MedAssets, (MDAS) Crushed on Weak Guidance, Performance
NutriSystem (NASDAQ:NTRI), Novatel Wireless, (NASDAQ:NVTL) MedAssets and (NASDAQ:MDAS) were all getting hammered on weak guidance and/or performance.
Guidance continues to be the story this earnings season, as companies with great last quarters are punished if they hint that's not going to be the case going forward.
Novatel Wireless (NVTL) was 16.8% lower after hours; reporting a fourth quarter adj-EPS of breakeven, $0.01 lower than the analyst estimate of $0.01. Revenue for the quarter was at $119.3 million versus the consensus estimate of $114.68 million. Guidance was for first quarter adj-loss of 36-48 cents, vs. the consensus of a 4 cents gain. Sales are expected to reach $60-$80 million, vs. the Street estimate of $103.8 million.
NutriSystem (NTRI) dropped by 28.3% after hours, reporting fourth quarter EPS of $0.25, level with the analyst estimate of $0.25. Revenue for the quarter came in at $87.9 million versus the consensus estimate of $100.64 million. Guidance if for a first quarter loss of $0.30-$0.35, versus the consensus of $0.30 profit. The company sees a full year 2011 profit of $0.40-$0.50, versus the consensus of $1.14.
MedAssets (MDAS) fell 16% after reporting fourth quarter EPS of $0.18, $0.04 lower than the analyst estimate of $0.22. Revenue for the quarter came in at $106.9 million versus the consensus estimate of $122.17 million.
Guidance continues to be the story this earnings season, as companies with great last quarters are punished if they hint that's not going to be the case going forward.
Novatel Wireless (NVTL) was 16.8% lower after hours; reporting a fourth quarter adj-EPS of breakeven, $0.01 lower than the analyst estimate of $0.01. Revenue for the quarter was at $119.3 million versus the consensus estimate of $114.68 million. Guidance was for first quarter adj-loss of 36-48 cents, vs. the consensus of a 4 cents gain. Sales are expected to reach $60-$80 million, vs. the Street estimate of $103.8 million.
NutriSystem (NTRI) dropped by 28.3% after hours, reporting fourth quarter EPS of $0.25, level with the analyst estimate of $0.25. Revenue for the quarter came in at $87.9 million versus the consensus estimate of $100.64 million. Guidance if for a first quarter loss of $0.30-$0.35, versus the consensus of $0.30 profit. The company sees a full year 2011 profit of $0.40-$0.50, versus the consensus of $1.14.
MedAssets (MDAS) fell 16% after reporting fourth quarter EPS of $0.18, $0.04 lower than the analyst estimate of $0.22. Revenue for the quarter came in at $106.9 million versus the consensus estimate of $122.17 million.
Subscribe to:
Posts (Atom)